Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
about
Neuroprotection for ischemic stroke: past, present and futureUse of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trialsCiticoline in addictive disorders: a review of the literatureMitochondrial function in hypoxic ischemic injury and influence of agingCombined clinical and imaging information as an early stroke outcome measureImaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery.Foundations of advanced magnetic resonance imaging.Clinical review: Imaging in ischaemic stroke--implications for acute managementUse of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence.The citicoline brain injury treatment (COBRIT) trial: design and methods.The role of citicoline in neuroprotection and neurorepair in ischemic stroke.Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review.Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyApplications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke.CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement.Final infarct volume estimation on 1-week follow-up MR imaging is feasible and is dependent on recanalization status.Eight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults.Magnesium in stroke treatment.Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trialsClinical trials for cytoprotection in stroke.Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery.Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders.Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy.Intra- and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI.Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE)Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant.Interventional neuroradiology of stroke, still not dead.Is aura around citicoline fading? A systemic review.Combination therapies for traumatic brain injury: prospective considerations.The approximate planimetric method: a simple, rapid and reliable method for estimation of lesion size in acute ischemic stroke.Exploratory Use of Decision Tree Analysis in Classification of Outcome in Hypoxic-Ischemic Brain Injury.Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry.
P2860
Q24645185-4FE01703-4356-4005-BC9A-7411C3359B46Q24793478-3A04DECC-C86B-4A3F-896A-6E2FDC759468Q27014895-40B95F1C-5FFE-4738-898E-21B68F3B2E80Q28396663-8C62B391-8B01-454D-B99B-34B919FA5CE0Q30308632-7A4A1F0A-CA0F-46CB-B872-D8CFBE4FFF92Q30409698-00676C4E-D173-4327-8828-F228D3434ED8Q30499144-D8E35937-C284-49F1-8B3A-47C0D7ABADE4Q33299284-0A6000A4-9F7A-4122-A66D-F4DB55DB37E3Q33525255-07A1B7F5-7B38-45DE-9402-13B1C0B36FB8Q33666576-AB344C41-5466-4D0B-9478-B986B6AA9114Q33772185-8F228F61-D384-4837-B770-AC1CC36E805FQ33978760-78B17865-77B7-413C-949E-EB7BBCFB2381Q34002942-EC4DC760-11CA-4271-8390-527743D652AAQ34175020-0576155E-67F3-4F53-B1F3-5A6499F881C1Q34358553-E7F94632-2458-4652-A101-6C60A9609760Q34545798-90A1FAA8-E61E-4EB1-9980-BC39CAFFA8B1Q34852058-36994400-1B0D-4D44-BB0E-714208E9AD3CQ35032195-B6D8CCD3-B258-490A-8BC9-B467794AE15FQ35268048-1EBDA2E6-96CF-4FAF-8676-B9DE28C969CFQ36045223-E3373ACB-C228-4B16-BC8C-582E77BF91DCQ36496980-8763F614-392F-4A96-8652-AC74BA1ADEB2Q36561991-44F141FC-6AFF-4B8A-B42D-9F4100CCB79DQ36578554-930B99DA-0E79-4236-985B-BCAF610EB2F7Q36623736-E0381B7F-CD1E-4B8F-B1F7-B016B5C9902EQ37252669-2823D212-136F-4873-A60E-2F3FA5795118Q37340226-60458E67-18B5-4D49-AFEF-726627E1D8BCQ37417777-03E9F721-7C60-4235-8D2B-107FE4D9D529Q37701011-C72D14C0-F685-4EF4-AECC-C49AF4D86987Q42616360-EE924415-A733-40F5-8C44-04D242AFCE02Q48341750-5D6B3C04-84B0-4145-BF69-181A7E449E28Q51761098-D526D4A2-9F54-4FBD-8651-0A577B916C24Q55408544-34CECA5E-4977-45C7-8611-AFC66A2B69E4
P2860
Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effect of citicoline on ischem ...... Citicoline 010 Investigators.
@ast
Effect of citicoline on ischem ...... Citicoline 010 Investigators.
@en
type
label
Effect of citicoline on ischem ...... Citicoline 010 Investigators.
@ast
Effect of citicoline on ischem ...... Citicoline 010 Investigators.
@en
prefLabel
Effect of citicoline on ischem ...... Citicoline 010 Investigators.
@ast
Effect of citicoline on ischem ...... Citicoline 010 Investigators.
@en
P2093
P1433
P1476
Effect of citicoline on ischem ...... Citicoline 010 Investigators.
@en
P2093
Lefkowitz DM
Pettigrew LC
Pullicino P
Sabounjian L
Schwiderski U
P304
P356
10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.3.CO;2-R
P577
2000-11-01T00:00:00Z